Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE)
Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE)
批准号:
10647455
负责人:
Gordon R Bernard
金额:
$228.71万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-01 至 2029-04-30
关键词:
Acute Respiratory Distress SyndromeAdherenceAttenuatedBig DataBiologicalBiometryCaliforniaCaringClassificationClinicalClinical ResearchClinical Trials Data Monitoring CommitteesCognitiveCommunicationCommunitiesCompensationComplexContractsCritical IllnessDataData CollectionDedicationsDevelopmentElectronic Health RecordEnrollmentEnsureEvolutionFailureFoundationsGoalsGroupingHeterogeneityImageIndividualInfrastructureInvestigationKnowledgeLeadershipManualsMeasurementMeasuresMedicalMethodsMissionMonitorMorbidity - disease rateOperations ResearchOutcomeParticipantPatientsPharmacotherapyPhenotypePneumoniaPopulationPrecision therapeuticsProcessProtocols documentationRecoveryReportingReproducibilityResearchResearch DesignResearch InfrastructureRisk FactorsSan FranciscoScienceSecuritySepsisSiteStandardizationStatistical Data InterpretationSyndromeTherapeuticTrainingTraining SupportTranslatingTranslational ResearchTrustUniversitiesWorkbiobankcareer developmentclinical centercohortcommunity engagementdata infrastructuredata managementdata modelingdata qualitydesignefficacious treatmentelectronic consentexperienceimprovedindividual patientinnovationknowledge basemortalitymultimodalitynovel therapeuticsoperationpatient populationpatient subsetsperformance sitepersonalized managementphenotyping algorithmpoint of careprecision medicineprofiles in patientsprognosticprotocol developmentrecruitskill acquisitionskillssuccesssynergismtargeted treatmenttreatment responsevirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ARDS, Pneumonia, and Sepsis (APS) Coordinating Center will support a highly functional
and integrated clinical and translational research infrastructure that will enhance the quality and
scientific rigor of the research conducted by the APS Phenotyping Consortium. We are a team
composed of leading content and methods experts at Vanderbilt, Johns Hopkins, and University
of California San Francisco. We will provide Coordination for ARDS, Pneumonia, and Sepsis
supporting Training, Organization and Network Efficiency: ‘CAPSTONE’. We will support the
clinical centers (CCs) in enrolling and sustaining a diverse cohort; enable the efficient and
standardized capture of multi-modal cohort data with repeated measurements; model the data to
understand mechanistic underpinnings of APS, including the interplay of underlying and static risk
factors; and segment the population into similar prognostic and predictive phenotypes. This will
enable scientific progress towards a deeper mechanistic understanding of critical illness
syndromes and recovery. Functionally, we will 1) Implement the study design, data capture, and
statistical analysis unit. Coordinate protocol development; establish a REDCap-based data
collection, management, and security framework; conduct and support analyses; generate
reports; make curated data widely available for research through a facilitated storefront; 2)
Implement the clinical research management unit. Maintain cohort integrity and adherence to the
protocol and manual of operations, perform routine monitoring of data quality and site
performance; training of study staff; image and biospecimen management. Support site
communications; facilitate recruitment and retention; and 3) Implement the stakeholder
engagement and development unit. Establish bidirectional, longitudinal engagement from diverse
communities; help CCs build and sustain trust; ensure strengths of each CC are nurtured and
shared; facilitate dissemination of findings; support skills and career development among
research teams. Our efforts will expand foundational work on APS phenotyping, identify gaps,
and help create methods for redefining critical illness syndromes with the ultimate goal of
improving and personalizing management strategies that will curtail the devastating morbidity and
mortality caused by APS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ComPASS Collective for Community Engagement (C3E)
-
批准号:10903370
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2023
-
负责人:Gordon R Bernard
-
依托单位:
Engaging Cooperative Sites for Trial Acceleration, Trust, Innovation, and Capability (ECSTATIC)
-
批准号:10650682
-
项目类别:
-
资助金额:$516.98万
-
财政年份:2023
-
负责人:Gordon R Bernard
-
依托单位:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
-
批准号:10398799
-
项目类别:
-
资助金额:$158.37万
-
财政年份:2021
-
负责人:Gordon R Bernard
-
依托单位:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
-
批准号:10609049
-
项目类别:
-
资助金额:$158.37万
-
财政年份:2021
-
负责人:Gordon R Bernard
-
依托单位:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
-
批准号:10084583
-
项目类别:
-
资助金额:$158.37万
-
财政年份:2021
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasma
-
批准号:10254565
-
项目类别:
-
资助金额:$56.3万
-
财政年份:2020
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:10170009
-
项目类别:
-
资助金额:$9.65万
-
财政年份:2020
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:9490464
-
项目类别:
-
资助金额:$799.21万
-
财政年份:2017
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:9414517
-
项目类别:
-
资助金额:$802.06万
-
财政年份:2017
-
负责人:Gordon R Bernard
-
依托单位:
Passive Immunity Trial for Our Neighbors (PassITON): A randomized, placebo-controlled multi-site trial of anti-SARS-CoV-2 convalescent plasma to treat hospitalized adults with COVID-19
-
批准号:10218949
-
项目类别:
-
资助金额:$3400.0万
-
财政年份:2017
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:10591572
-
项目类别:
-
资助金额:$1095.41万
-
财政年份:2017
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:10523600
-
项目类别:
-
资助金额:$1099.06万
-
财政年份:2017
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:8830542
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2014
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:9108435
-
项目类别:
-
资助金额:$75.75万
-
财政年份:2013
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:8422894
-
项目类别:
-
资助金额:$68.96万
-
财政年份:2013
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:9270134
-
项目类别:
-
资助金额:$39.71万
-
财政年份:2013
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:8722602
-
项目类别:
-
资助金额:$73.17万
-
财政年份:2013
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:9043520
-
项目类别:
-
资助金额:$2.2万
-
财政年份:2013
-
负责人:Gordon R Bernard
-
依托单位:
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:8499470
-
项目类别:
-
资助金额:$67.32万
-
财政年份:2012
-
负责人:Gordon R Bernard
-
依托单位:
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:9308216
-
项目类别:
-
资助金额:$11.05万
-
财政年份:2012
-
负责人:Gordon R Bernard
-
依托单位:
海外基金